Orders of magazines and newspapers ship free anywhere in U.S.

The Opioid Reckoning | Barron's, Sept. 23, 2019

The Opioid Reckoning | Barron's, Sept. 23, 2019

Regular price $13.00 Sale

Barron's print edition as published Sept. 23, 2019.

      On the Cover: The Opioid Reckoning - Lawsuits against drugmakers and distributors have rocked their stocks. What comes next—and what investors need to know. By Josh Nathan-Kazis

      Also in this issue:

      • Microsoft, Delta, and Comcast Fit the Bill - Some predict a 38% chance of recession in the next year. Here are seven stocks that can grow even if the economy doesn’t. By Jack Houg
      • The RealReal’s Appeal Over Other 2019 IPOs. By Nicholas Jasinski
      • The Buffalo International fund’s Nicole Kornitzer scours the globe for companies that can deliver consistent growth. By Sarah Max 
      • Climate Risk Looms Large for U.S. Munis. By Leslie P. Norton
      • Microcap Stocks - Jim Mitchell’s namesake fund has earned a reputation for impressive returns in tiny, thinly traded stocks. By Al Root

      VOL. XCIX No. 38

      Pages: 72